The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management?

By Lebeurrier Nathalie   Vivien Denis   Ali Carine  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 4, 2004-08 ,pp. : 309-320

Informa Healthcare

Access to resources Recommend Favorite

Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 3, 2008-06 ,pp. : 243-253

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model

By Umemura K.   Ishiye M.   Kosuge K.   Nakashima M.  

European Journal of Pharmacology, Vol. 275, Iss. 1, 1995-02 ,pp. : 17-21

Elsevier

Access to resources Recommend Favorite

Ultrasound-responsive thrombus treatment with zinc-stabilized gelatin nano-complexes of tissue-type plasminogen activator

By Uesugi Yoshiko   Kawata Hiroyuki   Saito Yoshihiko   Tabata Yasuhiko  

Journal of Drug Targeting, Vol. 20, Iss. 3, 2012-04 ,pp. : 224-234

Informa Healthcare

Access to resources Recommend Favorite

Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 2, 2013-04 ,pp. : 155-169

Bentham Science Publishers

Access to resources Recommend Favorite